title: Termination of the CRESCENDO trial.
authors.forename: Shawn G
authors.initials: SG
authors.lastname: Kwatra
mesh_terms: D019440:Anti-Obesity Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D003866:Depressive Disorder / Q000150:complications; D005060:Europe; D006801:Humans; D015337:Multicenter Studies as Topic; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects*; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D000077285:Rimonabant; D013405:Suicide / Q000523:psychology / Q000706:statistics & numerical data*; D017211:Treatment Failure
chemical_list: D019440:Anti-Obesity Agents; D002317:Cardiovascular Agents; D010880:Piperidines; D011720:Pyrazoles; D019389:Cytochrome P-450 CYP2D6; D000077285:Rimonabant